Fundamental Analysis
65 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -46.4% | +181.4% | 2 / 3 | +39.7% | +8.85 pp | +1.58 pp | +2.2% | 0.80 | 28.79 | 209 | +39,7% | 16,6 | +74,3% | 28.79 | 53.99 | −46,7% |
| Pts | 0 | 12 | 8 | 12 | 12 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 6.900 (close price on 2026-10-19)EPS (TTM): 239,6
Financial charts
1.Revenue & growth
VND bn209Q2/26
1.Revenue & growth
VND bn209Q2/26
2.Profit & growth
VND bn5,79Q2/26
3.Profit mix (Penman)
VND bn32,6Q2/26
4.Margins & cost structure
%14.9%Q2/26
5.Returns & cash cycle
% · days3.4%Q2/26
6.Earnings quality & cash
VND bn982Q2/26
7.Asset structure
VND bn3.529Q2/26
8.Funding & debt health
VND bn · times3.529Q2/26
9.Revenue backlog
VND bn498Q2/26
10.Valuation
times · %28,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %60Q2/26
Adjusted EPS growth, latest quarter
-46.4%
Average adjusted EPS growth, 3 quarters
22.3%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26